Informing the policy process: from efficacy to effectiveness data on pharmacotherapy.
Health care delivery is rapidly changing, but are the right data available to inform the policy process? This article illustrates the use of observational data on quality and effectiveness of treatment for anticipating the consequences of alternative forms of health care delivery, with psychotropic medications used as the example. The data are from the Medical Outcomes Study. Patients in each specialty sector (general medical provider, psychiatrist, psychologist or master's-level therapist) have unique profiles of use of appropriate psychotropics, and there is less appropriate and less efficient medication management in prepaid than fee-for-service care, especially within psychiatry. Overall, effective psychotropic medications are underused, reducing the cost-effectiveness of care. Improving the quality of psychotropic medication management would improve patient functioning outcomes and cost effectiveness of care, but in the absence of compensating strategies, it would also raise treatment costs.
Wells
K B
KB
RAND, Santa Monica, California 90407-2138, USA.
Sturm
R
R
D003695:Delivery of Health Care / Q000191:economics / Q000592:standards; D003866:Depressive Disorder / Q000188:drug therapy; D004358:Drug Therapy / Q000191:economics*; D006801:Humans; D011570:Psychiatry